N6-Methylation of Adenosine (M6A) of FZD10 mRNA Contributes to PARP Inhibitor Resistance

Cancer Research - United States
doi 10.1158/0008-5472.can-18-3592
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Transcription Impacts the Efficiency of mRNA Translation via Co-Transcriptional N6-Adenosine Methylation

Cell
BiochemistryGeneticsMolecular Biology
2017English

CAPAM: The mRNA Cap Adenosine N6-Methyltransferase

Trends in Biochemical Sciences
BiochemistryMolecular Biology
2019English

M6A mRNA Methylation: A New Circadian Pacesetter

Cell
BiochemistryGeneticsMolecular Biology
2013English

M6A mRNA Methylation Regulates CTNNB1 to Promote the Proliferation of Hepatoblastoma

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2019English

F-Box Protein-Mediated Resistance to PARP Inhibitor Therapy

Molecular Cell
Cell BiologyMolecular Biology
2019English

Circadian Clock Regulation of Hepatic Lipid Metabolism by Modulation of M6A mRNA Methylation

Cell Reports
BiochemistryGeneticsMolecular Biology
2018English

RING Domain–deficient BRCA1 Promotes PARP Inhibitor and Platinum Resistance

Journal of Clinical Investigation
Medicine
2016English

Methylation of HIF3A Promoter CpG Islands Contributes to Insulin Resistance in Gestational Diabetes Mellitus

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

Myocardial Glucose Utilization. Failure of Adenosine to Alter It and Inhibition by the Adenosine Analogue N6-(L-2-Phenylisopropyl)adenosine

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy